Business Context and Reporting Period
Company: iSpecimen Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: March 5, 2024
Reporting Period: Event date of March 5, 2024
Business Context: The Company, an emerging growth company incorporated in Delaware, entered into a material definitive agreement to facilitate an equity offering.
Key Financial Metrics
This filing does not report operational financial metrics such as revenue, profit, cash flow, margins, or debt levels. The primary financial data point disclosed is the potential capital raise:
- Maximum Offering Size: $1,500,000 aggregate offering price.
- Security Type: Common Stock, par value $0.0001 per share.
- Underwriting Compensation: Up to 3.0% of the gross sales price of shares sold.
Material Changes
The material change reported is the execution of an At the Market Offering Agreement (ATM Agreement) with Rodman & Renshaw LLC as the sales agent. This agreement allows the Company to issue and sell shares from time to time through the sales agent on the Nasdaq Capital Market or other existing trading markets. The Company retains the right to designate the maximum amount of stock to be sold and may suspend or terminate the offering at its sole discretion.
Guidance, Outlook, and Risks
Management Commentary: The filing confirms the Company has no obligation to sell any shares under the agreement. Sales are subject to market conditions and the Company's ability to designate a minimum sales price.
Risks and Contingencies:
- Market Risk: The Company may instruct the agent not to sell shares if sales cannot be effected at or above a designated price.
- Legal Liability: The Company has agreed to indemnify the sales agent against certain liabilities, including those under the Securities Act.
- Termination: Either party may terminate the agreement at any time upon written notice.
Investor Verification Checklist
- Verify the current share price of ISPC on the Nasdaq Capital Market to assess potential dilution from the $1.5 million offering.
- Review the full text of the ATM Agreement (Exhibit 10.1) for specific termination clauses and indemnification details.
- Check subsequent filings to determine if and when the Company has elected to sell shares under this agreement.
- Confirm the Company's current cash position in the most recent 10-Q or 10-K to understand the necessity of this capital raise.